Reduction in antibiotic prescribing for respiratory tract infections is needed!

被引:21
作者
Mölstad, S [1 ]
机构
[1] Unit Res & Dev Primary Care, SE-55185 Jonkoping, Sweden
关键词
antibiotics; general practice; prescribing; primary care; respiratory tract infections; PENICILLIN-RESISTANT PNEUMOCOCCI; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MAXILLARY SINUSITIS; GENERAL-PRACTICE; PNEUMONIA; DIAGNOSIS; CHILDREN; ADULTS;
D O I
10.1080/02813430310003273
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In general practice, approximately 25% of consultations are related to infectious diseases. The emergence and spread of resistant bacteria are related to antibiotic use on an individual and on a community level. Antibiotic prescribing differs profoundly from one European country to the next, though there is no evidence of differences in the prevalence of infectious diseases. Most respiratory tract infections are self-limiting conditions, and recent evidence shows that antibiotics only slightly modify the course of most respiratory tract infections. The general practitioner should focus on patients with more severe symptoms who might benefit more from antibiotic treatment. In general, antibiotics should be prescribed for acute pneumonia. In addition, we may offer antibiotics to a selected group of patients with more severe symptoms of maxillary sinusitis, pharyngotonsillitis and acute exacerbation of chronic obstructive pulmonary disease/chronic bronchitis. In the diagnostic procedure, rapid tests of Streptococcus pyogenus and C-reactive protein may be valuable in carefully selected cases. Penicillins (penicillin V, amoxycillin) should be the first choice in most respiratory tract infections. Larger studies in general practice are needed to analyse the impact of antibiotic prescribing on morbidity, the occurrence of rare complications and spread of resistance. The greatest challenge will be to implement current knowledge in daily praxis.
引用
收藏
页码:196 / 198
页数:3
相关论文
共 20 条
[1]  
AGUILAR JW, 2003, COCHRANE LIB
[2]  
Arason VA, 1996, BMJ-BRIT MED J, V313, P387
[3]  
ARROLL B, 1999, COCHRANE LIB
[4]   Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence [J].
Ball, P ;
Baquero, F ;
Cars, O ;
File, T ;
Garau, J ;
Klugman, K ;
Low, DE ;
Rubinstein, E ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) :31-40
[5]   A European study on the relationship between antimicrobial use and antimicrobial resistance [J].
Bronzwaer, SLAM ;
Cars, O ;
Buchholz, U ;
Mölstad, S ;
Goettsch, W ;
Veldhuijzen, IK ;
Kool, JL ;
Sprenger, MJW ;
Degener, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (03) :278-282
[6]   Variation in antibiotic use in the European Union [J].
Cars, O ;
Mölstad, S ;
Melander, A .
LANCET, 2001, 357 (9271) :1851-1853
[7]  
DELMAR CB, 1999, COCHRANE LIB
[8]   PREDICTING ACUTE MAXILLARY SINUSITIS IN A GENERAL-PRACTICE POPULATION [J].
HANSEN, JG ;
SCHMIDT, H ;
ROSBORG, J ;
LUND, E .
BRITISH MEDICAL JOURNAL, 1995, 311 (6999) :233-236
[9]  
Hopstaken RM, 2003, BRIT J GEN PRACT, V53, P358
[10]   Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults [J].
Lindbaek, M ;
Hjortdahl, P ;
Johnsen, ULH .
BMJ-BRITISH MEDICAL JOURNAL, 1996, 313 (7053) :325-329